Mindray North America Reaches Important Ultrasound Milestone Through Partnership with Hillcrest Medical Center
Developer of Living Technology™ Reaches 100th Sale of Flagship Resona 7 Ultrasound System while Achieving Double Digit Growth Year Over Year
Mahwah, New Jersey – September 3, 2019 – Mindray, a global developer of next generation medical devices and software, today announced the sale of its 100th flagship Resona 7 Ultrasound System in North America to Hillcrest Medical Center in Tulsa, Oklahoma, a leading healthcare provider for the region. The company also indicates it has experienced double digit growth in North America year over year due to the growing demand for its ultrasound imaging solutions.
“Our Resona 7 System has rapidly gained acceptance from leading healthcare providers with more than 2,000 systems installed worldwide,” said Maher Elhihi, director, ultrasound marketing, Mindray. Elhihi continued, “According to the industry-leading Klein Biomedical Consultants’ 2018 report on the Medical Diagnostic Ultrasound Market in the USA, ultrasound revenues grew 10 percent in 2018 for the U.S. With these sales milestones, our ultrasound business outpaced the market growth and Mindray North America became one of the top four largest ultrasound suppliers in the U.S. per the Klein report.”
Powered by ZONE Sonography® Technology+ (ZST+), the Resona 7 Ultrasound System Sapphire Edition is designed to address the changing needs of today’s value-based healthcare environment. The system delivers crystal clear imaging with unrivaled detail resolution and image uniformity coupled with the industry’s best investment protection. In addition, based on Mindray’s Living Technology™, which enables easily upgradable ultrasound enhancements and applications as they are developed, the Resona 7 System includes five years of software updates to ensure that Mindray’s customers remain at the cutting-edge of imaging performance.
“A key factor in choosing the Resona 7 System was the ongoing upgrades Mindray continues to develop,” said Suzanne Bean, supervisor of ultrasound at Hillcrest. “This helps us to remain at state-of-the-art imaging while protecting our investment in the future. It provides an excellent value proposition along with superb imaging capabilities, supporting excellence in patient care.”
About Hillcrest Medical Center
For more than a 100 years, Hillcrest Medical Center has provided an environment of hope, health and healing. The 620-bed hospital is among Oklahoma’s most widely respected and acclaimed hospitals, offering extraordinary care and a multitude of services in many areas. Hillcrest Medical Center is a premier provider of health care services, delivered with compassion for patients and their families; with respect for employees, physicians and other health professionals; with accountability for our fiscal and ethical performance; and with responsibility to the communities we serve. For further information, visit www.hillcrestmedicalcenter.com.
Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world.